Lectures and seminars StratRegen Seminar Series with Yuval Rinkevich
Welcome to a new seminar in the StratRegen Lunch Seminar Series on THURSDAY the 28th of May 2026, 12.30-13.30 in seminar room Eva & Georg Klein, Biomedicum, Campus Solna with live interactive stream to DNA 5105, Neo, lobby floor, Flemingsberg.

Title: Emerging perspectives in wound healing
Speaker: Professor Yuval Rinkevich, Chinese Institutes For Medical Research, Beijing (CIMR)
Publications
Distinct fibroblast assemblies establish scarless regeneration.
Ye H, Yu Q, Lee AJKS, Dong W, Chang Z, Correa-Gallegos D, Jiang D, Dai R, Schorpp K, Hadian K, Machens HG, Rinkevich Y
Cell Rep 2026 Jan;45(1):116767
A mesothelial differentiation gateway drives fibrosis.
Kadri S, Fischer A, Mück-Häusl M, Han W, Kadri A, Lin Y, Yang L, Hu S, Ye H, Ramesh P, Ansari M, Schiller HB, Machens HG, Rinkevich Y
Nat Commun 2025 Sep;16(1):8295
Targeting pleuro-alveolar junctions reverses lung fibrosis in mice.
Fischer A, Han W, Hu S, Mück-Häusl M, Wannemacher J, Kadri S, Lin Y, Dai R, Christ S, Su Y, Dasgupta B, Sardogan A, Deisenhofer C, Dutta S, Kadri A, Güney TG, Correa-Gallegos D, Mayr CH, Hatz R, Stoleriu MG, Lindner M, Hilgendorff A, Adler H, Machens HG, Schiller HB, Hauck SM, Rinkevich Y
Nat Commun 2025 Jan;16(1):173
CD201+ fascia progenitors choreograph injury repair.
Correa-Gallegos D, Ye H, Dasgupta B, Sardogan A, Kadri S, Kandi R, Dai R, Lin Y, Kopplin R, Shenai DS, Wannemacher J, Ichijo R, Jiang D, Strunz M, Ansari M, Angelidis I, Schiller HB, Volz T, Machens HG, Rinkevich Y
Nature 2023 Nov;623(7988):792-802
Wound infiltrating adipocytes are not myofibroblasts.
Kalgudde Gopal S, Dai R, Stefanska AM, Ansari M, Zhao J, Ramesh P, Bagnoli JW, Correa-Gallegos D, Lin Y, Christ S, Angelidis I, Lupperger V, Marr C, Davies LC, Enard W, Machens HG, Schiller HB, Jiang D, Rinkevich Y
Nat Commun 2023 May;14(1):3020
Sandwiches and coffee will be provided.

Host
Enric Llorens Bobadilla
Assistant ProfessorElif Eroglu
Principal ResearcherStratRegen supports researchers, research programs and infrastructure at the Karolinska Institutet (KI) within the field of stem cells and regenerative medicine based on scope, quality, and the potential to strengthen and develop the field.
